The American Red Cross (ARC) works to prevent and alleviate human suffering in the face of emergencies and is constantly working to increase the availability of blood and blood products. As part of the 10-year, $1 billion strategic capital investment program, the ARC’s most important goals for the new Atlanta region were the safety of product, supplies and staff, as well as overall image. The new 182,000 sf blood processing center supports blood collections, component processing, and blood product distribution. The two-story center includes administrative and executive spaces, donor suitability, education, production planning, donor recruitment, and telemarketing. The facility was designed to meet current Good Manufacturing Practice standards, and comply with the intent of the FDA Code of Federal Regulations for blood handling and processing. Through the design, process flow of people, product, waste, supplies and information through the facility is being optimized and standardized.
"The Red Cross selected EwingCole from among nationwide firms for a 10-year Strategic Capital Investment Program (SCIP) involving the master planning & construction of four new and six existing Blood Processing Service Centers at various locations throughout the United States, encompassing nearly $500 million in construction."